title: A rare case of plasmacytoma of the ovary: a case report and literature review.
abstract: OBJECTIVE
  Extramedullary plasmacytomas are rare. Ovarian plasmacytomas, for which treatment options vary, are more unique and even more rare. We will consider the option of optimal cytoreductive surgery followed by adjuvant chemotherapy consisting of carboplatin (AUC-2) to prevent massive ascites and pleural effusion.
  
  
  METHODS
  We report a case of ovarian plasmacytoma in a 35-year-old woman presenting with abdominal pain due to the mass. She underwent optimal cytoreductive surgery. A post-operative histopathologic diagnosis of ovarian plasmacytoma was confirmed. She was assigned stage IIC disease. She received three cycles of single agent carboplatin for rapidly refilling ascites and pleural effusion. Her response was dramatic. There is no evidence of recurrence clinically for more than 14 months. The patient is receiving follow-up care.
  
  
  CONCLUSIONS
  Multimodality treatment comprising of optimal cytoreductive surgery followed by carboplatin-based chemotherapy is a novel observation and may be an option for the treatment of these rare tumours. This options needs to be further researched.
authors: Department of Gynaecologic Oncology, Kidwai Memorial Institute of Oncology, Dr. M.H. Mari Gowda Road, Bengaluru 560029, Karnataka, India.
authors: P
authors: P
authors: Shakuntala
authors: S
authors: S
authors: Praveen
authors: B
authors: B
authors: Shankaranand
authors: K
authors: K
authors: Rajshekar
authors: K
authors: K
authors: Umadevi
authors: Ud
authors: U
authors: Bafna
references: Gynecol Oncol. 1988 Mar;29(3):378-81
references: 3345956
references: South Med J. 1982 Apr;75(4):511-2
references: 6280325
references: J Chir (Paris). 1993 Mar;130(3):137-40
references: 8320301
references: Am J Clin Pathol. 2007 Aug;128(2):339-44
references: 17638671
references: Gynecol Oncol. 1999 Apr;73(1):151-4
references: 10094897
references: Cancer. 1999 Jun 1;85(11):2305-14
references: 10357398
references: Chin Med J (Engl). 2012 Aug;125(16):2948-50
references: 22932097
references: Gynecol Oncol. 1984 May;18(1):115-8
references: 6425122